Pilar Morande
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
N-acetylcysteine exerts senescence-selective antifibrotic effects in fibroblast from chronic wounds in recessive dystrophic epidermolysis bullosa.
Journal: The British journal of dermatology
Published: December 11, 2025
KLHL24 mutation drives intermediate filament degradation, mitochondrial dysfunction and fibrosis in heart failure patients.
Journal: Cardiovascular research
Published: November 04, 2024
Epidemiology of epidermolysis bullosa in Chile.
Journal: The British journal of dermatology
Published: March 30, 2024
Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study.
Journal: Experimental dermatology
Published: October 23, 2023
Maintenance of chronicity signatures in fibroblasts isolated from recessive dystrophic epidermolysis bullosa chronic wound dressings under culture conditions.
Journal: Biological research
Published: November 30, 2022
Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
Journal: International wound journal
Published: June 23, 2022
Recessive dystrophic epidermolysis bullosa results in painful small fibre neuropathy.
Journal: Brain : a journal of neurology
Published: August 05, 2016
Molecular epidemiology of junctional epidermolysis bullosa: discovery of novel and frequent LAMB3 mutations in Chilean patients with diagnostic significance.
Journal: The British journal of dermatology
Published: August 03, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026